TrialThe oncologist2021

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.

Shaily Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.